IRIS
BRIGANTI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 28.391
NA - Nord America 15.374
EU - Europa 12.103
SA - Sud America 9.897
AF - Africa 718
OC - Oceania 95
Continente sconosciuto - Info sul continente non disponibili 16
AN - Antartide 2
Totale 66.596
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.588
SG - Singapore 11.994
BR - Brasile 8.232
CN - Cina 6.775
HK - Hong Kong 4.378
SE - Svezia 3.691
IT - Italia 2.942
VN - Vietnam 2.719
RU - Federazione Russa 1.639
DE - Germania 913
AR - Argentina 694
FI - Finlandia 535
IN - India 463
ID - Indonesia 431
GB - Regno Unito 428
CA - Canada 326
MX - Messico 301
EC - Ecuador 291
RO - Romania 278
NL - Olanda 276
BD - Bangladesh 256
JP - Giappone 242
IE - Irlanda 234
ZA - Sudafrica 225
IQ - Iraq 203
ES - Italia 200
CO - Colombia 193
FR - Francia 190
TR - Turchia 187
AT - Austria 168
PL - Polonia 168
PY - Paraguay 138
UA - Ucraina 104
PK - Pakistan 101
CL - Cile 94
VE - Venezuela 93
MA - Marocco 92
EG - Egitto 84
PE - Perù 79
UZ - Uzbekistan 76
AU - Australia 75
IR - Iran 63
SA - Arabia Saudita 56
UY - Uruguay 53
LT - Lituania 52
KE - Kenya 51
TN - Tunisia 51
NG - Nigeria 50
AE - Emirati Arabi Uniti 45
DZ - Algeria 43
NP - Nepal 39
JO - Giordania 38
DO - Repubblica Dominicana 35
IL - Israele 34
AZ - Azerbaigian 33
KZ - Kazakistan 30
AL - Albania 28
CH - Svizzera 26
BE - Belgio 25
BG - Bulgaria 24
GR - Grecia 24
MY - Malesia 24
TW - Taiwan 23
BO - Bolivia 21
CZ - Repubblica Ceca 21
NO - Norvegia 20
KR - Corea 19
JM - Giamaica 17
PA - Panama 17
PH - Filippine 17
RS - Serbia 17
LB - Libano 16
TZ - Tanzania 16
BH - Bahrain 15
BA - Bosnia-Erzegovina 14
HN - Honduras 14
OM - Oman 14
PT - Portogallo 14
SN - Senegal 14
TH - Thailandia 14
AO - Angola 12
CR - Costa Rica 12
GT - Guatemala 12
HU - Ungheria 12
KW - Kuwait 12
PS - Palestinian Territory 12
BB - Barbados 11
BY - Bielorussia 11
KG - Kirghizistan 11
NZ - Nuova Zelanda 11
SV - El Salvador 11
TT - Trinidad e Tobago 11
HR - Croazia 10
XK - ???statistics.table.value.countryCode.XK??? 10
LV - Lettonia 9
SC - Seychelles 9
AM - Armenia 8
GA - Gabon 8
SY - Repubblica araba siriana 8
CI - Costa d'Avorio 7
Totale 66.430
Salva come PNG Salva come JPEG
Città #
Singapore 4.610
Hong Kong 4.351
Dallas 4.100
Hefei 1.800
Shanghai 1.784
Lawrence 1.712
Princeton 1.707
Ashburn 1.443
Ho Chi Minh City 1.049
Milan 685
São Paulo 648
Moscow 567
New York 557
Hanoi 554
Beijing 541
Helsinki 410
Los Angeles 362
Rio de Janeiro 255
Dublin 229
Boardman 209
Rome 198
Munich 181
Belo Horizonte 174
Nuremberg 163
Brasília 156
Tokyo 133
Brooklyn 132
Warsaw 129
Montreal 122
Porto Alegre 121
Curitiba 118
Da Nang 110
Johannesburg 110
Haiphong 108
Santa Clara 108
Denver 101
Guangzhou 97
Campinas 96
Salvador 95
Guayaquil 93
Turku 93
Chicago 89
Turin 89
Quito 88
Stockholm 85
Atlanta 84
Chennai 83
Orem 81
Thái Bình 80
Biên Hòa 79
Guarulhos 79
Poplar 76
Valencia 76
Ribeirão Preto 75
Pune 74
Mexico City 73
Vienna 72
Tianjin 68
Houston 67
Manaus 67
London 66
Tashkent 66
Toronto 66
Hải Dương 65
Naples 65
Washington 64
Baghdad 63
Boston 62
Buenos Aires 61
Fortaleza 60
Caxias do Sul 59
Seattle 59
Jakarta 58
Phoenix 58
Lima 57
Amsterdam 56
Frankfurt am Main 56
Bologna 55
Goiânia 55
Florence 53
Dhaka 52
Santo André 52
The Dalles 52
Bogotá 51
Hangzhou 51
Recife 50
Council Bluffs 47
Manchester 47
Mumbai 47
Ninh Bình 47
Osasco 47
Cape Town 45
Asunción 44
Columbus 44
Montevideo 43
Ankara 42
Nairobi 42
San Francisco 42
Sorocaba 42
Istanbul 41
Totale 33.828
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 1.631
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 1.361
Benign Prostatic Hyperplasia and Its Aetiologies 424
Women's sexual dysfunction: a pathophysiological review 277
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study 179
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 174
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 162
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 148
A comparative review of apomorphine formulations for erectile dysfunction - Recommendations for use in the elderly 138
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 126
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 122
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma 119
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 117
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 112
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging 112
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 109
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 109
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 108
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum 107
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 106
120-MONTH MEDIAN FOLLOW-UP OF INTRACAVERNOUS INJECTION THERAPY FOR ERECTILE DYSFUNCTION 104
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 104
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 103
ROBOT-ASSISTED RADICAL PROSTATECTOMY IS ASSOCIATED WITH FASTER AND GREATER RECOVERY FROM ORGASM ASSOCIATED INCONTINENCE 102
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 101
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 101
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 100
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores 100
A CRITICAL APPRAISAL OF THE ABILITY OF BODY MASS INDEX (BMI) TO PREDICT HIGH-GRADE PROSTATE CANCER (PCA) 100
A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation 100
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 100
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 98
A propensity score approach for treatment evaluation based on Bayesian Networks 97
30-DAY MORTALITY AFTER RADICAL PROSTATECTOMY IN OVER 9000 PATIENTS: VALIDATION OF A PREDICTIVE NOMOGRAM 96
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 94
A critical analysis of Permixon (TM) in the treatment of lower urinary tract symptoms due to benign prostatic enlargement 93
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 93
A mechanistic insight into the anti-metastatic role of the prostate specific antigen 93
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 91
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 90
A MINIMUM OF 14 CORES SHOULD BE TAKEN AT BIOPSY BEFORE PLANNING ACTIVE SURVEILLANCE FOR PATIENTS WITH LOW-RISK PROSTATE CANCER 89
Prediction of Sexual Function After Radical Prostatectomy 89
Pelvic lymph node dissection in prostate cancer 89
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 89
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 89
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma 87
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis 87
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 86
Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study 86
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer 86
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 86
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study 84
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient 84
18F-FDG PET/CT AND UROTHELIAL CARCINOMA: IMPACT ON MANAGEMENT AND PROGNOSIS—A MULTICENTER RETROSPECTIVE STUDY IN BOOK ROLE OF MEDICAL IMAGING IN CANCERS 83
Holmium laser enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up 83
[11C]choline PET/CT for the detection of tumor recurrence in prostate cancer patients with PSA<1.5 ng/mL 83
Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. 82
Prediction of Functional Outcomes After Nerve-Sparing Radical Prostatectomy: Results of Conditional Survival Analyses 82
[11C]CHOLINE PET/CT FOR RESTAGING PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY AND NO EVIDENCE OF DISEASE ON CONVENTIONAL IMAGING 80
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 80
[11C]CHOLINE PET/CT for Early Detection of Tumor in Prostate Cancer Patients with PSA Level Lower Than 1.5 NG/ML 79
ADC in the evaluation of side-specific extracapsular extension of prostate cancer: development and internal validation of a nomogram of clinical utility 79
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 79
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 78
How to Select the Optimal Candidates for Renal Mass Biopsy 78
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 77
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies 77
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 76
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 75
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 75
68Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study 75
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 74
A critical analysis of vardenafil in the management of patients with erectile dysfunction: an integration of the literature and collective personal experience. 74
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer 74
Preoperative Erectile Function Represents a Significant Predictor of Postoperative Urinary Continence Recovery in Patients Treated With Bilateral Nerve Sparing Radical Prostatectomy 74
Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve 73
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 73
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 73
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 73
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 72
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 72
Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis 72
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 72
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy 72
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 71
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 71
A risk calculator predicting recurrence in lymph node metastatic penile cancer 71
Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration 71
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 71
Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought 71
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 71
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 71
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 70
Reply to: Antonio Andrea Grosso, Agostino Tuccio, Matteo Salvi, Daniele Paganelli, Andrea Minervini, and Fabrizio Di Maida's Letter to the Editor re: Paolo Capogrosso, Eugenio Ventimiglia, Giuseppe Fallara, et al. Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.03.018 70
FATTORI PREDITTIVI DI LINFORREA DOPO PROSTATECTOMIA RADICALE E LINFOADENECTOMIA PELVICA 70
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 70
Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study 70
Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? 69
When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool 69
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 69
Totale 12.326
Salva come PNG Salva come JPEG
Categoria #
all - tutte 596.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 596.637
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021240 0 0 0 0 0 205 4 1 21 6 3 0
2021/20221.070 0 46 34 465 59 58 95 67 33 60 43 110
2022/20238.186 3.963 1.456 485 71 52 806 299 458 256 84 137 119
2023/20243.873 149 212 329 296 296 576 217 374 84 317 466 557
2024/202521.950 3.055 567 362 532 501 1.791 2.795 1.625 4.147 3.499 1.417 1.659
2025/202631.818 4.411 5.881 6.281 10.082 4.211 952 0 0 0 0 0 0
Totale 67.660